Investegate announcements from Biognosys AG, Biognosys Presenting Novel Cancer Research on its Proteomics Platforms and Advancing Data Analysis with the Launch of Proteoverse™ at the AACR Annual Meeting 2023
In collaboration with prominent biopharma companies and academic institutions, Biognosys will demonstrate the technological advances and versatility of the TrueDiscovery, TrueTarget, and TrueSignature
Houston company Axiom Space has a huge science haul planned for its debut mission, including robots and filters that could assist with future space exploration at the moon or Mars.
Fred Hutch prostate cancer researcher Dr. John Lee receives NIH New Innovator Award for developing lab-based cancer models that better mimic human tumors.